Talk:Cytomegalovirus vaccine

__DTSUBSCRIBEBUTTONDESKTOP__{"headingLevel":2,"name":"h-Rod57-2014-07-07T08:38:00.000Z","type":"heading","level":0,"id":"h-What_incentives-2014-07-07T08:38:00.000Z","replies":["c-Rod57-2014-07-07T08:38:00.000Z-What_incentives"],"text":"What incentives","linkableTitle":"What incentives"}-->

What incentives

__DTELLIPSISBUTTON__{"threadItem":{"headingLevel":2,"name":"h-Rod57-2014-07-07T08:38:00.000Z","type":"heading","level":0,"id":"h-What_incentives-2014-07-07T08:38:00.000Z","replies":["c-Rod57-2014-07-07T08:38:00.000Z-What_incentives"]}}-->
__DTSUBSCRIBEBUTTONMOBILE__{"headingLevel":2,"name":"h-Rod57-2014-07-07T08:38:00.000Z","type":"heading","level":0,"id":"h-What_incentives-2014-07-07T08:38:00.000Z","replies":["c-Rod57-2014-07-07T08:38:00.000Z-What_incentives"],"text":"What incentives","linkableTitle":"What incentives"}-->

Article says "Development of such a vaccine has been emphasized as a priority by the National Vaccine Program Office" but what funds are allocated to help its development and will US FDA give a vaccine any special consideration - eg Orphan status ? And what is view in EU ? - Rod57 (talk) 08:38, 7 July 2014 (UTC)[reply]__DTELLIPSISBUTTON__{"threadItem":{"timestamp":"2014-07-07T08:38:00.000Z","author":"Rod57","type":"comment","level":1,"id":"c-Rod57-2014-07-07T08:38:00.000Z-What_incentives","replies":[]}}-->